Versant Venture Capital VI, L.P. - 07 Jan 2026 SCHEDULE 13D/A Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager: Versant Venture Capital VI, L.P.
Reporting Manager: Versant Venture Capital VI, L.P.
Security: Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: GLUE
Shares outstanding: 65,785,529 shares
Disclosed Ownership: 2,236,708 shares
Ownership: 3.4%
Form type: SCHEDULE 13D/A
Filing time: 09 Jan 2026, 16:19:08 UTC
Date of event: 07 Jan 2026
Previous filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Managers (6)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Versant Venture Capital VI, L.P.	3.4%	2,236,708	2,236,708	0	/s/Max Eisenberg	Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P.	0001687880
Versant Ventures VI GP, L.P.	3.4%	2,236,708	0	2,236,708	/s/Max Eisenberg	Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the General Partner of Versant Ventures VI GP, L.P.	0001777654
Versant Ventures VI GP-GP, LLC	3.4%	2,236,708	0	2,236,708	/s/Max Eisenberg	Max Eisenberg/COO	0001777652
Versant Vantage I, L.P.	1.6%	1,013,361	1,013,361	0	/s/Max Eisenberg	Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P.
Versant Vantage I GP, L.P.	1.6%	1,013,361	0	1,013,361	/s/Max Eisenberg	Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the General Partner of Versant Vantage I GP, L.P.
Versant Vantage I GP-GP, LLC	1.6%	1,013,361	0	1,013,361	/s/Max Eisenberg	Max Eisenberg/COO